The global psoriatic arthritis therapeutics market is projected to grow at a CAGR of 6.5% in the forecast period of 2020-2025. The market growth is being driven by the growing health awareness among the consumers. North America is leading the regional market in the industry as a result of the increasing demand for the product, especially, from the United States.
Get a Free Sample Report with Table of Contents - Download Now
Properties and Applications
Psoriatic arthritis is a chronic disease associated with psoriasis. The condition needs timely treatment, the absence of which may lead to irreversible joint damage.
The psoriatic arthritis therapeutics market can be broadly categorised based on drug class, route of administration, and distribution channel.
Based on the drug class, the industry can be segmented into:
Based on the route of administration, the industry can be divided into:
Based on the distribution channel, the market can be divided into:
The EMR report looks into the regional markets of psoriatic arthritis therapeutics like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
The global psoriatic arthritis therapeutics market is being driven by the launch of new products, the increasing prevalence of psoriatic arthritis, and the growing consumer awareness regarding their health. Interleukin inhibitors are leading the drug class segment due to the rising emergence of biosimilars. North America, along with Europe, held more than half the overall market revenue in 2019 owing to rising commercial sales of products in the United States, the presence of key players, initiatives undertaken by the governments, the enactment of favourable policies, and the increasing incidence of psoriatic arthritis. The Asia Pacific is estimated to witness the fastest growth in the forecast period as a result of the increasing disposable income of consumers, improvement in healthcare facilities, economic growth, and the rising adoption of biosimilars in emerging markets such as China, India, and South Korea.
The report presents a detailed analysis of the following key players in the global psoriatic arthritis therapeutics market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Key Questions Answered in the Market Report:
1.1 Objectives of the Study
1.1.1 Research Objective
1.1.2 Key findings of the Study
2 Research Methodology
2.1 Data Extraction
2.2 Data Corroboration
2.3 Market Structure
2.4 Inference Data
3 Executive Summary
3.1 Market Overview
3.2 Market Analysis
4 Global Psoriatic Arthritis Therapeutics Market Analysis
4.1 Global Psoriatic Arthritis Therapeutics Historical Market (2015-2019) & Forecast (2020-2025)
4.2 Global Psoriatic Arthritis Therapeutics Market Breakup by Drug Class
4.2.1 TNF Inhibitors
4.2.2 Interleukin Inhibitors
4.2.3 PDE4 Inhibitors
4.3 Global Psoriatic Arthritis Therapeutics Market Breakup by Drug Class: Historical Market (2015-2019) & Forecast (2020-2025)
4.3.1 TNF Inhibitors
4.3.2 Interleukin Inhibitors
4.3.3 PDE4 Inhibitors
4.4 Global Psoriatic Arthritis Therapeutics Market Breakup by Route of Administration
4.5 Global Psoriatic Arthritis Therapeutics Market Breakup by Route of Administration: Historical Market (2015-2019) & Forecast (2020-2025)
4.6 Global Psoriatic Arthritis Therapeutics Market Breakup by Distribution Channel
4.6.1 Hospital Pharmacies
4.6.2 Retail Pharmacies
4.6.3 Online Pharmacies
4.7 Global Psoriatic Arthritis Therapeutics Market Breakup by Distribution Channel: Historical Market (2015-2019) & Forecast (2020-2025)
4.7.1 Hospital Pharmacies
4.7.2 Retail Pharmacies
4.7.3 Online Pharmacies
4.8 Global Psoriatic Arthritis Therapeutics Market Breakup by Region
4.8.1 North America
22.214.171.124 United States of America
126.96.36.199 United Kingdom
4.8.3 Asia Pacific
4.8.4 Latin America
4.8.5 Middle East & Africa
188.8.131.52 Saudi Arabia
184.108.40.206 United Arab Emirates
220.127.116.11 South Africa
4.9 Global Psoriatic Arthritis Therapeutics Market Breakup by Region: Historical Market (2015-2019) & Forecast (2020-2025)
4.9.1 North America
18.104.22.168 United States of America
22.214.171.124 United Kingdom
4.9.3 Asia Pacific
4.9.4 Latin America
4.9.5 Middle East & Africa
126.96.36.199 Saudi Arabia
188.8.131.52 United Arab Emirates
184.108.40.206 South Africa
5 SWOT Analysis
6 Porter’s Five Forces Analysis
6.2 Buyer’s Power
6.3 Supplier’s Power
6.4 New Entrants
6.5 Degree of Rivalry
7 Competitive Landscape & Supplier Analysis
7.1 AbbVie, Inc. (NYSE: ABBV)
7.1.1 Company Overview
7.1.2 Financial Analysis
7.2 Janssen Global Services LLC (Johnson & Johnson)
7.2.1 Company Overview
7.2.2 Financial Analysis
7.3 Novartis AG (SWX: NOVN)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.4 Amgen, Inc. (NASDAQ: AMGN)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.5 Celgene Corporation (NASDAQ: CELG)
7.5.1 Company Overview
7.5.2 Financial Analysis
7.6 Pfizer, Inc. (NYSE: PFE)
7.6.1 Company Overview
7.6.2 Financial Analysis
7.7 Eli Lilly and Company (NYSE: LLY)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.8 UCB SA. (EBR: UCB)
7.8.1 Company Overview
7.8.2 Financial Analysis
7.9 Biogen Inc. (NASDAQ: BIIB)
7.9.1 Company Overview
7.9.2 Financial Analysis
7.10 Bristol-Myers Squibb Company (NYSE: BMY)
7.10.1 Company Overview
7.10.2 Financial Analysis
8 Events and Developments
EMR is one of the foremost business intelligence and market research companies with a database of syndicated and customised reports spanning more than 100 industries across global and regional markets. We leverage the knowledge of our highly skilled team of over 100 analysts and more than 3000 independent consultants to provide our clients with thoroughly researched and reliable data tailored to their requirements. We help our clients, who range from Fortune 1000 companies to medium and niche enterprises, make informed strategic decisions through our varied tools and methodology.
Our meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. We understand the distinct nature and requirements for each industry and thus, modify our methodology to best fit the industry in question. Our research methodology uses a combination of cutting-edge analytical tools and the expertise of our highly accomplished team, thus, providing our customers with industry insights that are accurate, actionable, and help them remain ahead of their competition. EMR’ s fine-tuned research methodology and data analysis, formulated through years of cross-industry experience of our team, ensure that our clients are provided with:
Our approach gives our clients a comprehensive assessment of the prevailing and projected industry conditions through the collection, collation, and analysis of data from trusted sources.
We assess the historical, prevailing, and expected prices of commodities and raw materials by analysing our assiduously collected data from verified primary and secondary sources. Our assessments reflect the market values of related commodities within a region to help our consumers understand the interdependencies and formulate profitable industry strategies. Our price assessments cover both the average global prices along with the prevailing regional prices.
Our market assessments determine the global and regional production and consumption of the product, according to their value and volume. We identify the key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive overview of the competitive landscape to help our clients make informed strategic decisions. We also take into account the demographic, economic, cultural, and political factors that might influence the market.
We gather market intelligence through our extensive database of reliable secondary sources and our exhaustive interviews with multiple industry stakeholders. The information gathered through our primary and secondary sources help us verify and extrapolate data relating to prices, trade, and market fluctuations along with the latest developments in the industry.
As a part of our primary research, we interact with highly placed industrial professionals possessing an expansive and meticulous insight into the market. We conduct our interviews via mails, telephonic conversations, and one-on-one meetings. Thus, our exhaustive interviews with both buyers and consumers help us provide our clients with verified intelligence regarding the market size, share, drivers, prices, and forecast along with a detailed assessment of your supply chain.
EMR has access to extensive internal and subscribed databases, which apprise us of the historical and prevailing industry conditions and help us forecast the market for the coming few years. Our secondary research involves a wide array of sources ranging from the annual and financial reports of the key players in the industry to governmental and regulatory databases. We refer to various scientific and industry publications and whitepapers to form a comprehensive understanding of the product and the supply chain. Our wide-ranging research also refers to relevant articles and press releases to provide our customers with an up-to-date understanding of the contemporary market. We derive extensive raw data from our secondary research, which then go through a thorough verification and validation process, to help us formulate an exhaustive understanding of the industry, the supply chain, the competitive landscape, and the product.
Other Analyst Tools and Data Models
Our extensive and intricate data models, formulated through our propriety technological and analytical resources, help you easily comprehend the expansive market data and aid you in framing vital business and industry strategies. Our tools provide you with a cohesive understanding of the industry outlook, taking into account the qualitative and quantitative market variables. Our analytical tools and models are regularly updated according to the changes in the continually evolving market scenarios as well as being adapted to best meet our client’s specific needs. Our research methods involve a blend of the best technological tools used in the industry along with the expertise of our analysts and consultants who can spot and assess the implications of the subtle factors influencing the more complex markets.
Our market assessments take into consideration only those data that are confirmed and are derived from credible and transparent sources. Thus, our clients are presented with accurate and infallible data which can be incorporated into their business strategies.
Before our data is presented to the clients, they undergo an intensive cross-verification and validation process. We corroborate the data gathered through our primary and secondary research by the review and validation of the initial sources along with the verification of the data from other thoroughly vetted sources.
Our qualitative and quantitative assessments are time-sensitive, reflecting the most recent value and volume of the market across regions. By constantly updating our databases and reports to reflect the changes taking place in the industry, our market and price assessments accurately reflect the prevailing industry conditions.
Thus, our rigorous data collection, thorough statistical analysis, and specialist assessments ensure that our clientele has a greater understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors, helping them emerge as the undisputed industry leaders in their respective fields.
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
A thoracic surgery involves any chest organ treatment or operation including the heart, lungs, oesophagus, as well as trachea. Thoracic surgery is also recognised as chest surgery. Thoracic surgery is...
The global stretch marks treatment market is driven by the growing incidences of stretch marks across the globe. Further, the rising prevalence of obesity owing to the increasing fast food and changin...
Primary biliary cholangitis refers to a rare chronic disease of the liver, formerly referred to as primary biliary cirrhosis, mainly characterized by the degradation of the biliary ducts, which contai...
An upper respiratory tract infection (URTI) is an illness, which is the result of an acute infection involving a person’s upper respiratory tract like the nose, sinuses, pharynx, or larynx. The infe...
The global unicompartmental knee prostheses market is estimated to grow at a CAGR of almost 3.8% in the forecast period of 2020-2025. The global unicompartmental knee prostheses market is being driven...
Buy Full Version
"Psoriatic Arthritis Therapeutics Market" Purchase Enquiry